Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Annual shareholders meeting

On October 5,2012 enrollment was complete.The six month trials plus one month follow up (and MNKD) tells us that the Study 171 should be done this month.Since that is the trial that we need for approval (Study 175 is gravy) and the "BLIND" will soon see the trial data,don't you think that they can at least tell us at the ASM that a preliminary look at the data is encouraging,or something to that effect.I think we deserve that,at least.

Throw us a bone,Al.

Share
New Message
Please login to post a reply